Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1

被引:155
作者
Young-Pearse, Tracy L.
Chen, Allen C.
Chang, Rui
Marquez, Cesar
Selkoe, Dennis J. [1 ]
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
关键词
D O I
10.1186/1749-8104-3-15
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: beta-Amyloid precursor protein (APP) has been reported to play a role in the outgrowth of neurites from cultured neurons. Both cell-surface APP and its soluble, ectodomain cleavage product (APPs-alpha) have been implicated in regulating the length and branching of neurites in a variety of assays, but the mechanism by which APP performs this function is not understood. Results: Here, we report that APP is required for proper neurite outgrowth in a cell autonomous manner, both in vitro and in vivo. Neurons that lack APP undergo elongation of their longest neurite. Deletion of APLP1 or APLP2, homologues of APP, likewise stimulates neurite lengthening. Intriguingly, wild-type neurons exposed to APPs-alpha, the principal cleavage product of APP, also undergo neurite elongation. However, APPs-alpha is unable to stimulate neurite elongation in the absence of cellular APP expression. The outgrowth-enhancing effects of both APPs-alpha and the deletion of APP are inhibited by blocking antibodies to Integrin beta 1 (Itg beta 1). Moreover, full length APP interacts biochemically with Itg beta 1, and APPs-alpha can interfere with this binding. Conclusion: Our findings indicate that APPs-alpha regulates the function of APP in neurite outgrowth via the novel mechanism of competing with the binding of APP to Itg beta 1.
引用
收藏
页数:13
相关论文
共 44 条
[11]   Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease [J].
Hemming, Matthew L. ;
Selkoe, Dennis J. ;
Farris, Wesley .
NEUROBIOLOGY OF DISEASE, 2007, 26 (01) :273-281
[12]  
HOE HS, 2007, SOC NEUR 37 ANN C SA, V331, P313
[13]   A macromolecular complex involving the amyloid precursor protein (APP) and the cytosolic adapter FE65 is a negative regulator of axon branching [J].
Ikin, Annat F. ;
Sabo, Shasta L. ;
Lanier, Lorene M. ;
Buxbaum, Joseph D. .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2007, 35 (01) :57-63
[14]  
Jung SS, 1996, J NEUROSCI RES, V46, P336, DOI 10.1002/(SICI)1097-4547(19961101)46:3<336::AID-JNR7>3.3.CO
[15]  
2-L
[16]   Cleavage of amyloid-β precursor protein and amyloid-β precursor-like protein by BACE 1 [J].
Li, QM ;
Südhof, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :10542-10550
[17]   The multipolar stage in neuronal migration [J].
LoTurco, Joseph J. ;
Bai, Jilin .
TRENDS IN NEUROSCIENCES, 2006, 29 (07) :407-413
[18]   IMMUNOHISTOCHEMICAL LOCALIZATION OF BETA-AMYLOID PRECURSOR PROTEIN SEQUENCES IN ALZHEIMER AND NORMAL BRAIN-TISSUE BY LIGHT AND ELECTRON-MICROSCOPY [J].
MCGEER, PL ;
AKIYAMA, H ;
KAWAMATA, T ;
YAMADA, T ;
WALKER, DG ;
ISHII, T .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 31 (03) :428-442
[19]   THE AMYLOID PROTEIN-PRECURSOR OF ALZHEIMERS-DISEASE IS A MEDIATOR OF THE EFFECTS OF NERVE GROWTH-FACTOR ON NEURITE OUTGROWTH [J].
MILWARD, EA ;
PAPADOPOULOS, R ;
FULLER, SJ ;
MOIR, RD ;
SMALL, D ;
BEYREUTHER, K ;
MASTERS, CL .
NEURON, 1992, 9 (01) :129-137
[20]  
MULLER U, 1995, MOL BIOL CELL, V6, P433